Read more

September 13, 2023
1 min read
Save

Top in endocrinology: Risks with COVID-19 vaccination; diabetic neuropathy pain relief

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The risk for thyroid eye disease is 3.2 times higher in adults, particularly those aged younger than 50 years, 28 days after receiving a vaccination against COVID-19.

“We suggest monitoring of young people, and those at risk for autoimmunity, undergoing COVID-19 vaccination,” Ilaria Muller, MD, PhD, told Healio. “A balanced and personalized harm-benefit analysis of COVID-19 vaccination should also be encouraged in these people, as well as those already affected with thyroid autoimmunity.”

Woman receiving a vaccine
Researchers said COVID-19 vaccines tripled the risk for thyroid eye disease, an autoimmune inflammation of the eye, between 1 and 28 days after immunization. Image: Adobe Stock

It was the top story in endocrinology last week.

In another top story, an implanted 10 kHz spinal cord stimulator yielded pain relief and quality of life improvements at 2 years for adults with painful diabetic neuropathy.

Read these and more top stories in endocrinology below:

Risk for thyroid eye disease rises within 4 weeks of COVID-19 vaccination

Adults may have an increased risk for new-onset or recurrent thyroid eye disease in the 28 days after receiving a COVID-19 vaccine dose, according to findings published in The Journal of Clinical Endocrinology & Metabolism. Read more.

Diabetic neuropathy pain relief with spinal cord stimulator sustained at 24 months

An implanted 10 kHz spinal cord stimulator plus conventional management was associated with pain relief and quality of life improvements at 2 years for adults with painful diabetic neuropathy, according to study findings. Read more.

Tubeless insulin pump receives FDA clearance for people with diabetes

The FDA in August cleared a tubeless insulin pump for use by people with diabetes who use insulin, according to a press release. Read more.

Early glycemic control may not prevent beta-cell deterioration in youth-onset diabetes

Youths with type 2 diabetes who had a lower mean HbA1c shortly after diagnosis have similar long-term beta-cell deterioration as those with a higher HbA1c, according to findings published in Diabetes Care. Read more.

Ketogenic diet may improve reproductive hormone levels in women with PCOS

Women with polycystic ovary syndrome could improve some reproduction hormone levels if they switch to a ketogenic diet, according to systematic review and meta-analysis published in the Journal of the Endocrine Society. Read more.